About Zealand Pharma

Company Description

Zealand Pharma A/S was founded in 1998 and is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. We intend to be a leader in specialty medicines focusing on metabolic and gastrointestinal diseases and other rare disease areas with significant unmet medical needs. Zealand employs more than 300 people in Denmark and the US and has a portfolio of medicines and product candidates, including license collaborations with Boehringer Ingelheim.

Our pipeline focusing on gastrointestinal, metabolic and other specialty diseases where we believe that the present standard of care is inadequate and where we have the resources to advance our peptide-based product candidates into the later stages of clinical development, including registration and commercialization, while opportunistically considering partnership relationships that may arise.

Year founded

1998

Headquarters

Sydmarken 11, 2860 Søborg – Denmark

Shareholder information

Shares outstanding

51,513,186

IPO

Jan. 1, 2000

Stock exchange(s)

Nasdaq Copenhagen

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.